Literature DB >> 20005794

iPS cells: mapping the policy issues.

Amy Zarzeczny1, Christopher Scott, Insoo Hyun, Jami Bennett, Jennifer Chandler, Sophie Chargé, Heather Heine, Rosario Isasi, Kazuto Kato, Robin Lovell-Badge, Kelly McNagny, Duanqing Pei, Janet Rossant, Azim Surani, Patrick L Taylor, Ubaka Ogbogu, Timothy Caulfield.   

Abstract

Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.

Mesh：

Year:  2009        PMID： 20005794     DOI： 10.1016/j.cell.2009.11.039

Source DB:  PubMed          Journal:  Cell        ISSN： 0092-8674            Impact factor:   41.582


  24 in total

1.  Stem cell banking: between traceability and identifiability.

Authors:  Bartha M Knoppers; Rosario Isasi
Journal:  Genome Med       Date:  2010-10-05       Impact factor: 11.117

2.  Regulation of stem cell-based therapies in Canada: current issues and concerns.

Authors:  Barbara von Tigerstrom; Thu Minh Nguyen; Bartha Maria Knoppers
Journal:  Stem Cell Rev Rep       Date:  2012-09       Impact factor: 5.739

3.  Cell therapy: cGMP facilities and manufacturing.

Authors:  Raffaella Giancola; Tiziana Bonfini; Antonio Iacone
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

4.  The ethics of moral compromise for stem cell research policy.

Authors:  Zubin Master; G K D Crozier
Journal:  Health Care Anal       Date:  2012-03

5.  From embryonic stem cells to iPS - an ethical perspective.

Authors:  J Suaudeau
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

6.  Stem cell policy exceptionalism: proceed with caution.

Authors:  Geoffrey P Lomax; Steven R Peckman
Journal:  Stem Cell Rev Rep       Date:  2012-06       Impact factor: 5.739

7.  Research ethics and stem cells: Is it time to re-think current approaches to oversight?

Authors:  Timothy Caulfield; Kalina Kamenova; Ubaka Ogbogu; Amy Zarzeczny; Jay Baltz; Shelly Benjaminy; Paul A Cassar; Marianne Clark; Rosario Isasi; Bartha Knoppers; Lori Knowles; Gregory Korbutt; James V Lavery; Geoffrey P Lomax; Zubin Master; Michael McDonald; Nina Preto; Maeghan Toews
Journal:  EMBO Rep       Date:  2014-12-04       Impact factor: 8.807

8.  The evolution of policy issues in stem cell research: an international survey.

Authors:  Timothy Caulfield; Christen Rachul; Amy Zarzeczny
Journal:  Stem Cell Rev Rep       Date:  2012-12       Impact factor: 5.739

9.  Patients' attitudes toward the donation of biological materials for the derivation of induced pluripotent stem cells.

Authors:  Ishan Dasgupta; Juli Bollinger; Debra J H Mathews; Neil M Neumann; Abbas Rattani; Jeremy Sugarman
Journal:  Cell Stem Cell       Date:  2014-01-02       Impact factor: 24.633

10.  Engineering Mammalian Cells to Control Glucose Homeostasis.

Authors:  Jiawei Shao; Xinyuan Qiu; Mingqi Xie
Journal:  Methods Mol Biol       Date:  2021
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.